Search Within

Stephen Shiu-Wah Chung

Formats
  1. Meeting Abstract (40)
  2. Journal Article (18)
  3. Book Section (3)
Groups
  1. Adult Leukemia (61)
  2. Center for Hematologic Malignancies (61)
  3. Department of Medicine (61)
  4. Hematologic Malignancies, Division of (61)
  5. GSK Faculty (33)
  6. Executive Committee, Center for Hematologic Malignancies (26)

More Groups

People
  1. Christopher Park (33)
  2. Jae Park (18)
  3. Virginia Klimek (18)
  4. Omar Abdel-Wahab (16)
  5. Ross Levine (15)
  6. Martin Tallman (14)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (3)
  4. 2017 (7)
  5. 2016 (8)
  6. 2015 (9)

More Years

Publications
  1. Blood (25)
  2. Experimental Hematology (5)
  3. Haematologica (4)
  4. Cancer Research (3)
  5. Science Translational Medicine (3)
  6. Current Opinion in Hematology (2)

More Publications

Publishers
  1. American Society of Hematology (27)
  2. Elsevier Science, Inc. (6)
  3. Ferrata Storti Foundation (4)
  4. Nature Publishing Group (4)
  5. American Association for Cancer Research (3)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (61)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: A single-centre, single-arm, phase 2 trial
    Journal Article

    Taylor, J.; Mi, X.; Penson, A. V.; Paffenholz, S. V.; Alvarez, K.; Sigler, A.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; more...
    The Lancet Haematology (2020)

    Fulltext@MSK | Save
  • CD97 is a critical regulator of acute myeloid leukemia stem cell function
    Journal Article

    Martin, G. H.; Roy, N.; Chakraborty, S.; Desrichard, A.; Chung, S. S.; Woolthuis, C. M.; Hu, W.; Berezniuk, I.; Garrett-Bakelman, F. E.; Hamann, J.; more...
    Journal of Experimental Medicine (2019)

    Fulltext@MSK | Save
  • Selinexor, a first-in-class XPO1 inhibitor, is efficacious and tolerable in patients with myelodysplastic syndromes refractory to hypomethylating agents
    Meeting Abstract

    Taylor, J.; Coleman, M.; Alvarez, K.; Pichardo, J.; Sen, F.; Chung, S. S.; Rampal, R. K.; Park, J. H.; Stein, E. M.; Tallman, M. S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies
    Journal Article

    Taylor, J.; Pavlick, D.; Yoshimi, A.; Marcelus, C.; Chung, S. S.; Hechtman, J. F.; Benayed, R.; Cocco, E.; Durham, B. H.; Bitner, L.; more...
    Journal of Clinical Investigation (2018)

    Fulltext@MSK | Save
  • Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes?
    Journal Article

    Tavakkoli, M.; Chung, S. S.; Park, C. Y.
    Expert Opinion on Therapeutic Targets (2018)

    Fulltext@MSK | Save
  • Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
    Meeting Abstract

    Durham, B. H.; Getta, B.; Dietrich, S.; Taylor, J.; Won, H.; Bogenberger, J. M.; Scott, S. N.; Kim, E.; Chung, Y. R.; Chung, S. S.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • CD99 regulates normal and malignant stem cell function by restricting protein translation
    Meeting Abstract

    Chung, S. S.; Hu, W.; Guo, L.; Kannan, L.; Levine, R. L.; Park, C. Y.
    Blood (2017)

    Fulltext@MSK | Save
  • An analysis of the transcriptional response of myelodysplastic syndrome stem cells to therapy at single-cell resolution
    Meeting Abstract

    Chung, S.; Vijay, P.; Klimek, V.; Mason, C.; Park, C.
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Aging, hematopoiesis, and the myelodysplastic syndromes
    Journal Article

    Chung, S. S.; Park, C. Y.
    Blood Advances (2017)

    Fulltext@MSK | Save
  • Aging, hematopoiesis, and the myelodysplastic syndromes
    Journal Article

    Chung, S. S.; Park, C. Y.
    Hematology-American Society of Hematology Education Program (2017)

    Fulltext@MSK | Save